These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 16480404

  • 1. The effect of over-the-counter ranitidine 75 mg on night-time heartburn in patients with erosive oesophagitis on daily proton pump inhibitor maintenance therapy.
    Vakil N, Guda N, Partington S.
    Aliment Pharmacol Ther; 2006 Mar 01; 23(5):649-53. PubMed ID: 16480404
    [Abstract] [Full Text] [Related]

  • 2. Nocturnal acid breakthrough in children with reflux esophagitis taking proton pump inhibitors.
    Pfefferkorn MD, Croffie JM, Gupta SK, Molleston JP, Eckert GJ, Corkins MR, Fitzgerald JF.
    J Pediatr Gastroenterol Nutr; 2006 Feb 01; 42(2):160-5. PubMed ID: 16456408
    [Abstract] [Full Text] [Related]

  • 3. Heartburn-dominant, uninvestigated dyspepsia: a comparison of 'PPI-start' and 'H2-RA-start' management strategies in primary care--the CADET-HR Study.
    Armstrong D, Veldhuyzen van Zanten SJ, Barkun AN, Chiba N, Thomson AB, Smyth S, Sinclair P, Chakraborty B, White RJ, CADET-HR Study Group.
    Aliment Pharmacol Ther; 2005 May 15; 21(10):1189-202. PubMed ID: 15882239
    [Abstract] [Full Text] [Related]

  • 4. Management of heartburn in a large, randomized, community-based study: comparison of four therapeutic strategies.
    Howden CW, Henning JM, Huang B, Lukasik N, Freston JW.
    Am J Gastroenterol; 2001 Jun 15; 96(6):1704-10. PubMed ID: 11419818
    [Abstract] [Full Text] [Related]

  • 5. Rabeprazole versus ranitidine for the treatment of erosive gastroesophageal reflux disease: a double-blind, randomized clinical trial. Raberprazole Study Group.
    Farley A, Wruble LD, Humphries TJ.
    Am J Gastroenterol; 2000 Aug 15; 95(8):1894-9. PubMed ID: 10950032
    [Abstract] [Full Text] [Related]

  • 6. Histamine 2 receptor antagonists vs intravenous proton pump inhibitors in a pediatric intensive care unit: a comparison of gastric pH.
    Tofil NM, Benner KW, Fuller MP, Winkler MK.
    J Crit Care; 2008 Sep 15; 23(3):416-21. PubMed ID: 18725049
    [Abstract] [Full Text] [Related]

  • 7. Symptomatic and endoscopic outcome of heartburn 3-4.5 years after starting lansoprazole therapy: a prospective study of 142 patients.
    Abu Farsakh N.
    J Gastroenterol; 2003 Sep 15; 38(11):1042-8. PubMed ID: 14673720
    [Abstract] [Full Text] [Related]

  • 8. The effect of H2-receptor antagonist and proton pump inhibitor on microbial proliferation in the stomach.
    Wang K, Lin HJ, Perng CL, Tseng GY, Yu KW, Chang FY, Lee SD.
    Hepatogastroenterology; 2004 Sep 15; 51(59):1540-3. PubMed ID: 15362796
    [Abstract] [Full Text] [Related]

  • 9. Double-blind, placebo-controlled study of ranitidine for gastroesophageal reflux symptoms during pregnancy.
    Larson JD, Patatanian E, Miner PB, Rayburn WF, Robinson MG.
    Obstet Gynecol; 1997 Jul 15; 90(1):83-7. PubMed ID: 9207819
    [Abstract] [Full Text] [Related]

  • 10. Clinical trial: acupuncture vs. doubling the proton pump inhibitor dose in refractory heartburn.
    Dickman R, Schiff E, Holland A, Wright C, Sarela SR, Han B, Fass R.
    Aliment Pharmacol Ther; 2007 Nov 15; 26(10):1333-44. PubMed ID: 17875198
    [Abstract] [Full Text] [Related]

  • 11. Therapy with gastric acidity inhibitors increases the risk of acute gastroenteritis and community-acquired pneumonia in children.
    Canani RB, Cirillo P, Roggero P, Romano C, Malamisura B, Terrin G, Passariello A, Manguso F, Morelli L, Guarino A, Working Group on Intestinal Infections of the Italian Society of Pediatric Gastroenterology, Hepatology and Nutrition (SIGENP).
    Pediatrics; 2006 May 15; 117(5):e817-20. PubMed ID: 16651285
    [Abstract] [Full Text] [Related]

  • 12. [Comparison between histamine H2-blocker and proton pump inhibitor on the effects of initial treatment in reflux esophagitis].
    Harasawa S.
    Nihon Rinsho; 2000 Sep 15; 58(9):1847-52. PubMed ID: 11004814
    [Abstract] [Full Text] [Related]

  • 13. Histamine H2 receptor antagonist-refractory oesophagitis: the efficacy of long-term omeprazole maintenance treatment.
    Bardhan KD, Cherian P, Jones RB, Vaishnavi A, Manek S, Bishop A, Polak J, Brooks A, Morris P, Thompson M, D'Silva J, Parkin S, Patterson J, Gillon KR.
    Ital J Gastroenterol Hepatol; 1997 Dec 15; 29(6):515-9. PubMed ID: 9513825
    [Abstract] [Full Text] [Related]

  • 14. Review article: putting immediate-release proton-pump inhibitors into clinical practice--improving nocturnal acid control and avoiding the possible complications of excessive acid exposure.
    Katz PO.
    Aliment Pharmacol Ther; 2005 Dec 15; 22 Suppl 3():31-8. PubMed ID: 16303035
    [Abstract] [Full Text] [Related]

  • 15. A single dose of ranitidine 150 mg modulates oesophageal acid sensitivity in patients with functional heartburn.
    Rodriguez-Stanley S, Ciociola AA, Zubaidi S, Proskin HM, Miner PB.
    Aliment Pharmacol Ther; 2004 Nov 01; 20(9):975-82. PubMed ID: 15521845
    [Abstract] [Full Text] [Related]

  • 16. Efficacy in intra-oesophageal acid suppression may decrease after 2-year continuous treatment with proton pump inhibitors.
    Frazzoni M, Manno M, De Micheli E, Savarino V.
    Dig Liver Dis; 2007 May 01; 39(5):415-21. PubMed ID: 17379591
    [Abstract] [Full Text] [Related]

  • 17. Differences in the diagnostic yield of upper gastrointestinal endoscopy in dyspeptic patients receiving proton-pump inhibitors and H2-receptor antagonists.
    Mitchell RM, Collins JS, Watson RG, Tham TC.
    Endoscopy; 2002 Jul 01; 34(7):524-6. PubMed ID: 12170401
    [Abstract] [Full Text] [Related]

  • 18. Onset of action of antisecretory drugs: beneficial effects of a rapid increase in intragastric pH in acid reflux disease.
    Pipkin GA, Mills JG.
    Scand J Gastroenterol Suppl; 1999 Jul 01; 230():3-8. PubMed ID: 10499455
    [Abstract] [Full Text] [Related]

  • 19. High- versus standard-dose ranitidine for control of heartburn in poorly responsive acid reflux disease: a prospective, controlled trial.
    Kahrilas PJ, Fennerty MB, Joelsson B.
    Am J Gastroenterol; 1999 Jan 01; 94(1):92-7. PubMed ID: 9934737
    [Abstract] [Full Text] [Related]

  • 20. Towards an increased efficacy of acid inhibition in the treatment of erosive oesophagitis.
    Lambert R.
    J Gastroenterol Hepatol; 1996 Oct 01; 11(10):897-9. PubMed ID: 8912122
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.